A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)

Part of paid clinical trials in Addison, Illinois.

Sponsor
Midwest Center for Metabolic and Cardiovascular Research
Study ID
NCT07789769
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Overweight , Obesity

Eligibility Criteria

Sex
ALL
Age
18 Years - 69 Years
Healthy Volunteers
Accepted

Interventions

  • 30-30-30 PFE Intervention — BEHAVIORAL
    Interactive, online weight loss program adapted from the Rx Weight Loss (Rx WL) program with additional goals to consume ≥30 g protein/meal (P) + ≥30 g fiber/day (F) + ≥30 minutes of daily exercise (E).
  • Standard — BEHAVIORAL
    Standard interactive, online weight loss program adapted from the Rx WL program.

Study Details

The purpose of this study is to learn whether following an online weight loss program with specific dietary and exercise goals (the 30-30-30 plan) can help improve weight loss and other markers of health when compared to an online weight loss program on its own.

Key Dates

First listed
Aug 27, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
110 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Standard
    Standard interactive, online weight loss program adapted from the Rx WL program.
  • Experimental: 30-30-30 PFE intervention
    Interactive, online weight loss program adapted from the Rx Weight Loss (Rx WL) program with additional goals to consume ≥30 g protein/meal (P) + ≥30 g fiber/day (F) + ≥30 minutes of daily exercise (E) (30-30-30 PFE intervention).

Primary Outcome Measure

Body Weight [ Time Frame: From week 0 to week 24 ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Biofortis Clinical ResearchAddisonIllinois60101
Gina Castiglione-Berg
[email protected]
6306172000
Aditi Shah, MD (PRINCIPAL_INVESTIGATOR)
Illinois Institute of TechnologyChicagoIllinois60616
Chelsea Preiss, MS
[email protected]
3125675308
Indika Edirisinghe, PhD (PRINCIPAL_INVESTIGATOR)
Indiana UniversityBloomingtonIndiana47405
Karen Sprague
[email protected]
812-855-7643
Nana Gletsu-Miller, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Addison, IL

By research site
Biofortis Clinical Research· Addison, ILIllinois Institute of Technology· Chicago, ILIndiana University· Bloomington, IN

Related Studies